Operating characteristics of the standard phase I clinical trial design
- 1 May 1999
- journal article
- Published by Elsevier BV in Computational Statistics & Data Analysis
- Vol. 30 (3), 303-315
- https://doi.org/10.1016/s0167-9473(98)00095-4
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Miscellanea. A stopping rule for the continual reassessment methodBiometrika, 1998
- A Random Walk Rule for Phase I Clinical TrialsBiometrics, 1997
- AN EXTENSION OF THE CONTINUAL REASSESSMENT METHODS USING A PRELIMINARY UP‐AND‐DOWN DESIGN IN A DOSE FINDING STUDY IN CANCER PATIENTS, IN ORDER TO INVESTIGATE A GREATER RANGE OF DOSESStatistics in Medicine, 1995
- Up-and-down designs. II. Exact treatment momentsPublished by Institute of Mathematical Statistics ,1995
- Up-and-down designs. I. Stationary treatment distributionsPublished by Institute of Mathematical Statistics ,1995
- A comparison of two phase I trial designsStatistics in Medicine, 1994
- Random Walks for Quantile EstimationPublished by Springer Science and Business Media LLC ,1994
- Design of Phase I and II Clinical Trials in Cancer: A Statistician's ViewCancer Investigation, 1984
- A Monte Carlo comparison of three up-and-down designs for dose rangingControlled Clinical Trials, 1983
- A Method for Obtaining and Analyzing Sensitivity DataJournal of the American Statistical Association, 1948